Your browser doesn't support javascript.
loading
Prioritization of Molecular Targets for Antimalarial Drug Discovery.
Forte, Barbara; Ottilie, Sabine; Plater, Andrew; Campo, Brice; Dechering, Koen J; Gamo, Francisco Javier; Goldberg, Daniel E; Istvan, Eva S; Lee, Marcus; Lukens, Amanda K; McNamara, Case W; Niles, Jacquin C; Okombo, John; Pasaje, Charisse Flerida A; Siegel, Miles G; Wirth, Dyann; Wyllie, Susan; Fidock, David A; Baragaña, Beatriz; Winzeler, Elizabeth A; Gilbert, Ian H.
Afiliación
  • Forte B; Wellcome Centre for Anti-Infectives Research, Division of Biological Chemistry and Drug Discovery, University of Dundee, Dundee, DD1 5EH, United Kingdom.
  • Ottilie S; Department of Pediatrics, School of Medicine, University of California, San Diego, La Jolla, California 92093, United States.
  • Plater A; Wellcome Centre for Anti-Infectives Research, Division of Biological Chemistry and Drug Discovery, University of Dundee, Dundee, DD1 5EH, United Kingdom.
  • Campo B; Medicines for Malaria Venture, 1215 Geneva, Switzerland.
  • Dechering KJ; TropIQ Health Sciences, 6534 AT, Nijmegen, The Netherlands.
  • Gamo FJ; Global Health, GSK, 28760-Tres Cantos, Madrid, Spain.
  • Goldberg DE; Division of Infectious Diseases, Department of Medicine and Department of Molecular Microbiology, Washington University School of Medicine, St. Louis, Missouri 63110, United States.
  • Istvan ES; Division of Infectious Diseases, Department of Medicine and Department of Molecular Microbiology, Washington University School of Medicine, St. Louis, Missouri 63110, United States.
  • Lee M; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, CB10 1SA, United Kingdom.
  • Lukens AK; Infectious Disease and Microbiome Program, Broad Institute, Cambridge, Massachusetts 02142, United States.
  • McNamara CW; Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, Massachusetts 02115, United States.
  • Niles JC; Calibr, a Division of The Scripps Research Institute, 11119 North Torrey Pines Road, La Jolla, California 92037, United States.
  • Okombo J; Department of Biological Engineering, Massachusetts Institute of Technology (MIT), Cambridge Massachusetts 02139-4307, United States.
  • Pasaje CFA; Department of Microbiology and Immunology, Columbia University Irving Medical Center, New York, New York 10032, United States.
  • Siegel MG; Department of Biological Engineering, Massachusetts Institute of Technology (MIT), Cambridge Massachusetts 02139-4307, United States.
  • Wirth D; Lgenia, Inc., Fortville, Indiana 46040, United States.
  • Wyllie S; Infectious Disease and Microbiome Program, Broad Institute, Cambridge, Massachusetts 02142, United States.
  • Fidock DA; Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, Massachusetts 02115, United States.
  • Baragaña B; Wellcome Centre for Anti-Infectives Research, Division of Biological Chemistry and Drug Discovery, University of Dundee, Dundee, DD1 5EH, United Kingdom.
  • Winzeler EA; Department of Microbiology and Immunology, Columbia University Irving Medical Center, New York, New York 10032, United States.
  • Gilbert IH; Division of Infectious Diseases, Department of Medicine, Columbia University Irving Medical Center, New York, New York 10032, United States.
ACS Infect Dis ; 7(10): 2764-2776, 2021 10 08.
Article en En | MEDLINE | ID: mdl-34523908

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Plasmodium / Malaria / Antimaláricos Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: ACS Infect Dis Año: 2021 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Plasmodium / Malaria / Antimaláricos Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: ACS Infect Dis Año: 2021 Tipo del documento: Article País de afiliación: Reino Unido